Methylphenidate as a causal test of translational and basic neural coding hypotheses
Preprint
Abstract
SUMMARY: Most systems neuroscience studies fall into one of two categories: basic science work aimed at understanding the relationship between neurons and behavior, or translational work aimed at developing treatments for neuropsychiatric disorders. Here we use these two approaches to inform and enhance each other. Our study both tests hypotheses about basic science neural coding principles and elucidates the neuronal mechanisms underlying new, clinically relevant behavioral effects of systemically administered methylphenidate (Ritalin). We discovered that orally administered methylphenidate, used clinically to treat Attention Deficit Hyperactivity Disorder (ADHD) and generally to enhance cognition (Lakhan & Kirchgessner, 2012; Maher, 2008), increases spatially selective visual attention, enhancing visual performance at only the attended location. And as predicted by our previous work (Ni et al., 2018), we found that this causal manipulation enhances vision in rhesus macaques specifically when it decreases the mean correlated variability of neurons in visual area V4. Our findings demonstrate that the visual system is a platform for understanding the neural underpinnings of both complex cognitive processes (basic science) and neuropsychiatric disorders (translation). Addressing basic science hypotheses, our results are consistent with a scenario in which methylphenidate has cognitively specific effects by working through naturally selective cognitive mechanisms. Clinically, our findings suggest that the often staggeringly specific symptoms of neuropsychiatric disorders may be caused and treated by leveraging general mechanisms.Keywords
All Related Versions
- Published version: Proceedings of the National Academy of Sciences, 119 (17).
This publication has 60 references indexed in Scilit:
- Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effectsBrain and Behavior, 2012
- The role of neuromodulators in selective attentionTrends in Cognitive Sciences, 2011
- Measuring and interpreting neuronal correlationsNature Neuroscience, 2011
- Control of visual cortical signals by prefrontal dopamineNature, 2011
- Methylphenidate enhances brain activation and deactivation responses to visual attention and working memory tasks in healthy controlsNeuroImage, 2011
- Methylphenidate and Atomoxetine Enhance Prefrontal Function Through α2-Adrenergic and Dopamine D1 ReceptorsJournal of the American Academy of Child & Adolescent Psychiatry, 2010
- Understanding the Effects of Stimulant Medications on Cognition in Individuals with Attention-Deficit Hyperactivity Disorder: A Decade of ProgressNeuropsychopharmacology, 2010
- Attention improves performance primarily by reducing interneuronal correlationsNature Neuroscience, 2009
- Attention – oscillations and neuropharmacologyEuropean Journal of Neuroscience, 2009
- Cognition-Enhancing Doses of Methylphenidate Preferentially Increase Prefrontal Cortex Neuronal ResponsivenessBiological Psychiatry, 2008